Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy
Lin Li(Kunming Medical University), Stephanie L. Gaw(University of California, San Francisco), Priya Jegatheesan(Santa Clara Valley Medical Center), Mary Prahl(University of California, San Francisco), Jordan Needens(Marshall University), Balaji Govindaswami(Pediatrics and Genetics), Mauricio Montaño(Gladstone Institutes), Taha Y. Taha(Gladstone Institutes), Leslie Myatt(Oregon Health & Science University), Megan A. Chidboy(Society for Maternal-Fetal Medicine), Emilia Basilio(University of California, San Francisco), Kara L. Lynch(University of California, San Francisco), Mónica Rincón(Oregon Health & Science University), Christine Y. Lin(Society for Maternal-Fetal Medicine), Mélanie Ott(Gladstone Institutes), Yusuke Matsui(Gladstone Institutes), Yarden Golan(Cornell University), Warner C. Greene(Gladstone Institutes), Arianna G. Cassidy(University of California, San Francisco), Nida Özarslan(Society for Maternal-Fetal Medicine), Dongli Song(Augusta University), Sirirak Buarpung(University of California, San Francisco), Veronica J. Gonzalez(University of California, San Francisco), Unurzul Jigmeddagva(Reproductive Science Center)
Cited by 4
Related Papers
The Challenge of Finding a Cure for HIV Infection
|Science|2009|850
HIV Latency
|Cold Spring Harbor Perspectives in Medicine|2011|513
Vitamins C and E to Prevent Complications of Pregnancy-Associated Hypertension
|New England Journal of Medicine|2010|402
Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2
|Nature Immunology|2024|338
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
|Science Translational Medicine|2021|237